Clinical Trial Update: Pharmacokinetic Comparison of Advate rAHF-PFM With Recombinate rAHF in Patients With Severe Hemophilia A [Phase 4]

View source ↗

Summary

Phase 4 trial comparing pharmacokinetics of Advate rAHF-PFM with Recombinate rAHF in patients with Hemophilia A; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Advate rAHF-PFM (antihemophilic factor (recombinant) with procoagulant activity)
• Recombinate rAHF (antihemophilic factor (recombinant) [human coagulation factor VIII])

Snippet

Sponsor: Baxalta now part of Shire | Conditions: Hemophilia A | Phase 4 | Status: COMPLETED | Results posted: 2013-03-26